FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

2291000036103: Lanzek (olanzapine 2.5 mg) tablet (trade product unit of use)


Status: current, Defined. Date: 31-Mar 2012. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3742011000168111 Lanzek (olanzapine 2.5 mg) tablet (trade product unit of use) en Fully specified name Active Case sensitive Australian Medicines Terminology module
3742461000168118 Lanzek 2.5 mg tablet en Synonym Active Case sensitive Australian Medicines Terminology module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Lanzek 2.5 mg tablet has manufactured dose form tablet true Inferred relationship Some
Lanzek 2.5 mg tablet has unit of use tablet true Inferred relationship Some 1235185507
Lanzek 2.5 mg tablet has Australian BoSS olanzapine true Inferred relationship Some 1235185506
Lanzek 2.5 mg tablet has intended active ingredient olanzapine true Inferred relationship Some 1235185506
Lanzek 2.5 mg tablet Is a trade product unit of use true Inferred relationship Some
Lanzek 2.5 mg tablet Is a Lanzek true Inferred relationship Some
Lanzek 2.5 mg tablet Is a olanzapine 2.5 mg tablet true Inferred relationship Some
Lanzek 2.5 mg tablet has manufactured dose form film-coated tablet false Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Lanzek 2.5 mg tablet, 28, blister pack has TPUU True Lanzek 2.5 mg tablet Inferred relationship Some 1
Lanzek 2.5 mg tablet, 28 has TPUU True Lanzek 2.5 mg tablet Inferred relationship Some 1

Reference Sets

Trade product unit of use reference set

Back to Start